10 drug(s) with this reaction
8,827 total reports
Acute Kidney Injury has been reported as an adverse reaction across 10 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 8,827 adverse event reports mention acute kidney injury in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with acute kidney injury, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have acute kidney injury listed in their FDA adverse event reports, sorted by report count:
In addition to acute kidney injury, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
10 drug(s) manufactured by Haleon Us Holdings Llc have acute kidney injury listed in their FDA adverse event reports: CALCIUM CARBONATE, DICLOFENAC SODIUM, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, and others.
There are a combined 8,827 reports of acute kidney injury across 10 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.